Keyphrases
Metastatic Melanoma
100%
Future Role
100%
Adoptive Cell Therapy
100%
Inhibitor Resistant
100%
Checkpoint Inhibitors
100%
Tumor-infiltrating Lymphocytes
75%
Tumor-infiltrating Lymphocyte Therapy
75%
Cell Death
50%
Trial Registration
25%
Clinical Trials
25%
Patient Characteristics
25%
Tumor Antigen
25%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
25%
Median Progression-free Survival
25%
Duration of Response
25%
Inhibitor Treatment
25%
Detailed Data
25%
Durable Response
25%
Cell Therapy
25%
Objective Response Rate
25%
Melanoma Treatment
25%
Targeted Tumor
25%
Immune Checkpoint Inhibitors
25%
Hard to Treat
25%
Medicine and Dentistry
T Cell
100%
Metastatic Melanoma
100%
Tumor Infiltrating Lymphocyte
100%
Cell Therapy
100%
Cell Death
33%
Synapsin I
33%
Clinical Trial
16%
Patient Characteristics
16%
Nodular Melanoma
16%
Progression Free Survival
16%
Tumor Antigen
16%
Immunotherapy
16%
T Lymphocyte
16%
Immune Checkpoint Inhibitor
16%